FRAXA Research Foundation has made a 2017 grant of $90,000 to Probal Banerjee, PhD, at the College of Staten Island (CUNY). He is exploring a therapeutic strategy based on correcting abnormalities in the PKCepsilon signaling pathway in Fragile X.
Read moreCorrecting Fragile X Syndrome Deficits by Targeting Neonatal PKCepsilon Signaling in the Brain
